8Suppliers
8Customers
0Debt Items
20Related Chains

Source-Backed Evidence Depth

Evotec SE (EVOTF) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

16Total relationships
4Distinct source URLs
0High confidence
0.720Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Evotec SE Suppliers

TickerNameConfidenceEvidence
DB Deutsche Bank Aktiengesellschaft 72% responding to cybersecurity incidents with defined roles and responsibilities that facilitate coordination between the Chief Information Security Officer (“CISO”) and the IT, compliance, and business…
DB Deutsche Bank Aktiengesellschaft 72% Reciprocal relationship from DB graph: Reciprocal relationship from EVOTF graph: Reciprocal relationship from DB graph: Reciprocal relationship from EVOTF graph: responding to cybersecurity incidents…
NVO Novo Nordisk A/S 72% responding to cybersecurity incidents with defined roles and responsibilities that facilitate coordination between the Chief Information Security Officer (“CISO”) and the IT, compliance, and business…
NVO Novo Nordisk A/S 72% Reciprocal relationship from NVO graph: Reciprocal relationship from EVOTF graph: responding to cybersecurity incidents with defined roles and responsibilities that facilitate coordination between th…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from EVOTF graph: responding to cybersecurity incidents with defined roles and responsibilities that facilitate coordination between …
SNYNF Sanofi 72% responding to cybersecurity incidents with defined roles and responsibilities that facilitate coordination between the Chief Information Security Officer (“CISO”) and the IT, compliance, and business…
VNDA Vanda Pharmaceuticals Inc. 72% marketing authorization, Evotec may then make applications to the other member states of the European Union. The other member states may either recognize the marketing authorization of the reference …
VNDA Vanda Pharmaceuticals Inc. 72% Reciprocal relationship from VNDA graph: Reciprocal relationship from EVOTF graph: Reciprocal relationship from VNDA graph: Reciprocal relationship from EVOTF graph: Reciprocal relationship from VNDA…

Evotec SE Customers

TickerNameConfidenceEvidence
MANU Manchester 72% North America. As global demand for flexible biologics capacity and for more affordable access to medicines increases, we intend to build a second J.POD ® facility in Toulouse, France. Europe is the …
MANU Manchester 72% Reciprocal relationship from MANU graph: Reciprocal relationship from EVOTF graph: North America. As global demand for flexible biologics capacity and for more affordable access to medicines increase…
MS-PK Morgan Stanley 72% vestors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them. The depositary collects fees for making distributions to investors by deducting th…
MS-PK Morgan Stanley 72% Reciprocal relationship from MS-PK graph: Reciprocal relationship from EVOTF graph: vestors depositing shares or surrendering ADSs for the purpose of withdrawal or from intermediaries acting for them…
QGEN Qiagen N.V. 72% Reciprocal relationship from QGEN graph: Reciprocal relationship from EVOTF graph: Reciprocal relationship from QGEN graph: Reciprocal relationship from EVOTF graph: ight-line basis over the lease te…
QGEN Qiagen N.V. 72% ight-line basis over the lease term. The future minimum lease payments under non-cancellable operating leases are approximately as follows: T€ 2009 4,019 2010 2,738 2011 2,704 2012 2,632 2013 2,632 T…
SNYNF Sanofi 72% ​ The following schedule shows the revenue in the financial year 2019: ​ ​ ​ ​ ​ ​ ​ ​ in k€ EVT Execute EVT Innovate Evotec Group Revenues Service fees and FTE-based research payments Recharges Comp…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from EVOTF graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from EVOTF graph: Reciprocal relationship from SN…

Evotec SE Debt Obligations

No debt relationships on recordNo publicly disclosed debt instruments or credit facilities found for Evotec SE.

Evotec SE Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Evotec SE.

Evotec SE Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Evotec SE.

Evotec SE Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
DB Deutsche Bank Aktiengesellschaft 100.00 1 ['supplier']
MANU Manchester 100.00 1 ['customer']
MS-PK Morgan Stanley 100.00 1 ['customer']
NVO Novo Nordisk A/S 100.00 1 ['supplier']
SNYNF Sanofi 100.00 1 ['customer', 'supplier']
BLTE Belite Bio, Inc 50.00 2
BLSH Bullish 50.00 2
BCDRF Banco Santander, S.A. 50.00 2
RSVR Reservoir Media, Inc. 50.00 2
ALXO ALX Oncology Holdings Inc. 50.00 2
BANL CBL International Limited 50.00 2
BLIV BeLive Holdings 50.00 2
CPT Camden Property Trust 50.00 2
REG Regency Centers Corporation 50.00 2
BLRX BioLineRx Ltd. 50.00 2
CMBT Cmb.Tech NV 50.00 2
ANL Adlai Nortye Ltd. 50.00 2
BRID Bridgford Foods Corporation 50.00 2
CMCM Cheetah Mobile Inc. 50.00 2
AMBR Amber International Holding Limited 50.00 2
🔐
EVOTF
Unlock EVOTF Supply Chain Data
Verified relationships include:
DBDeutsche Bank Aktiengesel…Supplier72%
DBDeutsche Bank Aktiengesel…Supplier72%
MANUManchesterCustomer72%
MANUManchesterCustomer72%
+12 more relationships locked
Subscribe, View plans →